baber/WOPTO huggingface dataset:
Patent AT-E180112-T1 (AT)
Inventor: BAUER ALFRED
IPC: H02H3/08
Filed: 1996-09-05
Granted: 1999-05-15
Abstract: The invention is directed to a circuit configuration for the detection of an excess temperature due to a current flow, in which a first resistor arrangement is thermally coupled to a second resistor arrangement, the resistance value of the second resistor arrangement producing a thermistor action. The current to be evaluated is flown through at least the first resistor arrangement. The first resistor arrangement is comprised of at least one SMD resistor, and the second resistor arrangement of at least one SMD resistor that acts as a thermistor. The second resistor arrangement is electrically connected to at least one contact surface of the printed circuit board which is electrically connected to the at least one SMD resistor of the first resistor arrangement.
Patent AT-E236139-T1 (AT)
Inventor: PITTERNA THOMAS
IPC: C07D277/20
Filed: 1996-09-05
Granted: 2003-04-15
Abstract: The invention relates to a process for preparing a compound of formula (I) in which A is chlorine or 3-methyl-4-nitroimino-perhydro-1,3,5-oxadiazin-5-yl; to intermediates used in this process; to the use of these intermediates; and to a process for the preparation of these intermediates. The compounds of formula (I) are valuable intermediates in the process of preparing pesticidal, especially insecticidal or acaricidal, formulations.
Patent AT-E451613-T1 (AT)
Inventor: RIVIELLO JOHN
IPC: G01N30/08
Filed: 1996-12-17
Granted: 2009-12-15
Abstract: An ion chromatographic apparatus and method for on-column preconcentration of trace ionic contaminants for quantitative trace analysis by ion chromatography. The method includes the multi-cycle, sequential steps of loading and purging of sample solution into and out of a sample injection loop to cumulatively preconcentrate a separator column with a cumulative amount of sample. Each purging step includes directing pressurized liquid, at a substantially constant rate and for a predetermined period of time to the sample injection loop, to drive up to about 98% of the known volume of the sample solution from the sample injection loop. In turn, this flushed volume of sample solution passes through an ion exchange resin column for concentration of the trace ionic contaminants in the resin.
Patent AT-E196470-T1 (AT)
Inventor: KOIKE HIROKI
IPC: C07D471/04
Filed: 1997-08-08
Granted: 2000-10-15
Abstract: This invention provides a compound of the formula: <CHEM>  and its pharmaceutically acceptable salts, wherein Ar<1> is selected from groups of the following formulae: <CHEM>  wherein,     R<1> and R<2> are independently hydrogen or C1-C6 alkyl;   W is (CH2)n wherein n is from 1 to 3, or -CH=CH-;   X is C1-C6 alkoxy or halo C1-C6 alkoxy; and   Ar<2> is phenyl optionally substituted by halogen atom.   These compounds are useful in the treatment of a gastrointestinal disorder, a central nervous system (CNS) disorder, an inflammatory disease, emesis, urinary incontinence, pain, migraine, sunburn, angiogenesis, diseases, disorders and adverse conditions caused by Helicobacter pylori, or the like in a mammalian subject, especially humans.
Patent AT-E232221-T1 (AT)
Inventor: BAUD JEAN-JACQUES
IPC: C08K5/00
Filed: 1997-10-06
Granted: 2003-02-15
Abstract: Component, with thickness at least 100 mu m, made from photodegradable thermoplastic material comprising polyolefin matrix, at least one colourant (to give matrix initial colour) and photodegradation agent, comprising at least one photoinitiator and one ligand, is claimed. Colourant contains at least one phototransformable colorant whose transformation leads to modification of initial colour visible to naked eye; and a gain in transparency to UV light; said modification being faster than gain in transparency and phototransformation takes place before photodegradation. Also claimed are case for cartridge used in sport or hunting made from photodegradable material; and cartridge comprising claimed article.
Patent AT-E272842-T1 (AT)
Inventor: COLLINGE JOHN
IPC: A61K31/445
Filed: 1997-10-15
Granted: 2004-08-15
Abstract: The present invention relates to a method for typing a sample of a prion or spongiform encephalopathy disease, a kit suitable for use in such a typing method, a method for identifying infection in an animal and/or tissue of bovine spongiform encephalopathy (BSE), a method for assessing and/or predicting the susceptibility of an animal to BSE, a kit for use in such an assessment and/or prediction method, a method for the treatment of a prion disease, and compounds suitable for such a method.
Patent AT-E274930-T1 (AT)
Inventor: EMERSON PAUL
IPC: A61M1/14
Filed: 1997-04-24
Granted: 2004-09-15
Abstract: An improved on-line, real time hemodialysis monitoring system for hemodialysis treatment, quantitates the rate and amount of a constituent, such as urea, removed during the hemodialysis treating by measuring the constituent concentrations as a function of time in the spent dialysate effluent from a hemodialysis machine. A quantity of the spent dialysate effluent is removed from the dialysate effluent waste line periodically for testing. A urea concentration time profile can be analyzed to determine the urea removal, KT/V, URR, SRI, and normalized protein catabolic rate (nPCR) indices. The hemodialysis monitoring system preferably can obtain a dialysate sample equilibrated with the blood prior to the start of a hemodialysis treatment. In a further aspect of the hemodialysis monitoring system includes a device for conducting two-pool analysis for taking into account the constituent concentration differences in the extracellular and intracellular spaces in the hemodialysis patient during the hemodialysis treatment to determine the intercompartmental transfer coefficient KI of a patient, which allows more precise adjustment of the hemodialysis prescription for the patient.
Patent AT-E216254-T1 (AT)
Inventor: SALINI ALBERTO
IPC: A61K9/48
Filed: 1997-05-20
Granted: 2002-05-15
Abstract: A description is given of new pharmaceutical compositions containing cyclosporine, combined with a carrier comprising at least a derivative of alpha-glycerophosphoric acid, such as alpha-glycerophosphorylcholine, alpha-glycerophosphorylserine, alpha-glycerophosphorylethanolamine and alpha-glycerophosphoryl-myo-inositol, which allow cyclosporine bioavailability to significantly increase.
Patent AT-E216341-T1 (AT)
Inventor: PAUKKUNEN VELI-MATTI
IPC: A21C9/08
Filed: 1997-12-01
Granted: 2002-05-15
Abstract: The present invention is related to the manufacture of a baked product with the product being enclosed in a wrapper. The product can be given good qualities including that desired surface portions of the product can be provided a crust similar to that achievable under open-pan baking conditions. The invention is implemented so that the dough is dosed into the baking volume formed by said sealed wrapper, subsequently baking the dough in said baking space formed by said sealed wrapper. In the wrapper, the wrapper area overlying the intended crust-formation area of the baked product is made of a moisture-permeable porous material capable of passing water vapour through its structure.
Patent AT-E234607-T1 (AT)
Inventor: SANDERSON IAN
IPC: A61K9/00
Filed: 1997-12-31
Granted: 2003-04-15
Abstract: The invention encompasses compositions for increased bioavailability through mucosal delivery comprising, preferably in powder form, an intimate mixture of an effective amount of a bioactive agent and a hydrophobically derivatized carbohydrate. The compositions can also contain a surface active agent preferably for delivery to gastrointestinal mucosa and ocular delivery.
Patent AT-E273139-T1 (AT)
Inventor: HOSOI NOBUYUKI
IPC: B41M5/00
Filed: 1998-02-17
Granted: 2004-08-15
Abstract: There is provided a recording medium comprising a substrate and an ink-receiving layer containing alumina hydrate formed thereon, wherein the alumina hydrate is present unoriented in the ink-receiving layer and a diffraction intensity fluctuation  delta in a diffraction pattern is not more than 5 %, when irradiating an electron beam to a cross section of the ink-receiving layer. <IMAGE>
Patent AT-E271704-T1 (AT)
Inventor: RUEHRIG MANFRED DR
IPC: G06K19/06
Filed: 1998-07-29
Granted: 2004-08-15
Abstract: A layer of anisotropic, magnetic, high permeability, low coercivity material (2), generates a maximum signal when its preferred axis is parallel to an external alternating magnetic field. A second layer of low permeability, high coercivity material of different magnetization has regions (5) that are transverse to the preferred axis (x). Sections (4) of the second layer's regions have gaps with different lengths in the preferred direction
Patent AT-E316818-T1 (AT)
Inventor: VAN DER MEER WALTERUS GIJSBERT
IPC: B01D63/12
Filed: 1998-12-22
Granted: 2006-02-15
Abstract: The invention relates to a coupling unit for coupling two tubular membrane elements of the kind used in membrane filter technology, forming extensions of one another. The coupling unit comprises a jacket piece which is provided at both its ends with sealing surfaces intended to engage the facing ends of the membrane elements to be coupled thereto. The sealing surfaces may be formed on the interior peripheral wall of the jacket piece to engage the exterior peripheral wall of the ends of the membrane elements. However, the sealing surfaces may also be formed on the cross-cut end surfaces of the jacket piece, and engage the cross-cut end walls of the membrane elements. The interior of the jacket piece may comprise an axially extending conduit portion to communicate with corresponding flow conduits in the membrane elements. <IMAGE>
Patent AT-E251732-T1 (AT)
Inventor: MERTZ OTTO
IPC: A47B91/06
Filed: 1998-02-24
Granted: 2003-10-15
Abstract: The foot (1) supporting the frame (8) has a ball-mounting (3) transmitting loads to the ground or other components, also a connecting component (5) with ball-head (4) forming a pivot-joint with the mounting. It comprises a plate (1a) on which an integral supporting boss (1c) is formed, protruding upwards. The annular end face of the boss forms the ball-mounting. The foot can be shaped from sheet-metal. The plate can be joined by a radius to the boss, the two having the same thickness of material. There can be an annular spigot (1b) at the outside plate edge, extending at right angles to the plate surface and in the opposite direction to the boss.
Patent AT-E245689-T1 (AT)
Inventor: HUBESCH BRUNO ALBERT JEAN
IPC: D06M13/46
Filed: 1993-05-03
Granted: 2003-08-15
Abstract: Compositions are disclosed containing fabric softener compound having two hydrophobic groups attached to the remainder of the compound through ester linkages (DEQA), said compositions being concentrated and containing viscosity/dispersibility modifiers which are single long chain cationic surfactants, highly ethoxylated nonionic surfactants and/or mixtures thereof. Premix mixtures of the DEQA and viscosity modifiers to lower the viscosity of the molten DEQA are disclosed. Processes for making aqueous liquid compositions from solid particulate compositions containing the DEQA and processes of softening fabrics with the compositions are also disclosed.
Patent AT-E260392-T1 (AT)
Inventor: NEUHOFER FRANZ JUN
IPC: E04F19/04
Filed: 1998-10-02
Granted: 2004-03-15
Abstract: A profiled fixing plate is screwed (19) to the base of the wall (W) to hold a trim panel (2). A complementary profiled fixing device (7) is attached to the trim panel and is detachably clipped (17) on by hooking the lower part over a projection on the fixing plate. Cable or pipework can pass through the space between wall and trim and is effectively concealed.
Patent AT-E241916-T1 (AT)
Inventor: CAVAZZA CLAUDIO
IPC: A61K33/24
Filed: 1998-03-10
Granted: 2003-06-15
Abstract: A medical food for diabetics is disclosed which comprises as characterizing active ingredients  gamma -linolenic acid and at least one alkanoyl-L-carnitine, e.g. acetyl-L-carnitine and/or propionyl-L-carnitine.
Patent AT-E337794-T1 (AT)
Inventor: MATHIESEN IACOB
IPC: A61N1/30
Filed: 1998-04-03
Granted: 2006-09-15
Abstract: A method is disclosed for delivering molecules such as pharmaceutical drugs and nucleic acids into skeletal muscle in vivo. The pharmaceutical drug or nucleic acid is first injected into the muscle at one or multiple sites. Immediately, or shortly after, injection, electrodes are placed flanking the injection site and a specific amount of electrical current is passed through the muscle. The electrical current makes the muscle permeable, thus allowing the pharmaceutical drug or nucleic acid to enter the cell. The efficiency of transfer permits robust immune responses using DNA vaccines and produces sufficient secreted proteins for systemic biological activity to be observed.
Patent AT-E320505-T1 (AT)
Inventor: LICHTENSTEIN ANATOLY V
IPC: C07H21/04
Filed: 1998-05-29
Granted: 2006-04-15
Abstract: A method of analysing a target nucleic acid sequence in a urine sample, said method comprising assaying said urine sample for the presence of said target nucleic acid sequence that has crossed the kidney barrier. The present invention provides a method for detecting a non-host nucleic acid sequence in a patient, said method comprising assaying a urine sample, obtained from an individual, for a nucleic acid sequence that: 
(i) is from outside the urinary tract, 
(ii) has crossed the kidney barrier, and 
(iii) does not originate from the patient's endogenous nucleic acid sequences, wherein contaminating nucleic acids in the urine sample comprising greater than 1000 base pairs, or 1000 nucleotides when denatured are removed from the sample prior to detection of said non-host nucleic acid.
Patent AT-E283047-T1 (AT)
Inventor: SAKODA SABURO
IPC: A61K31/00
Filed: 1998-08-10
Granted: 2004-12-15
Abstract: A medicine for treatment of multiple sclerosis comprising, as an effective component, ibudilast represented by the chemical formula (1) below. Ibudilast is effective to experimental autoimmune encephalomyelitis by oral administration, and is effective to multiple sclerosis which is a disease of a central nervous system. <CHEM>
Patent AT-E341626-T1 (AT)
Inventor: BAKKER ALEXANDER B H
IPC: G01N33/50
Filed: 1998-07-31
Granted: 2006-10-15
Abstract: The purification and isolation of various genes which encode mammalian cell surface polypeptides. Nucleic acids, proteins, antibodies, and other reagents useful in modulating development of cells, e.g., lymphoid and myeloid, are provided, along with methods for their use.
Patent AT-E236418-T1 (AT)
Inventor: QIN S JOE
IPC: G01D21/00
Filed: 1998-10-27
Granted: 2003-04-15
Abstract: An apparatus and method is disclosed for detecting, identifying, and classifying faults occurring in sensors measuring a process. If faults are identified in one or more sensors, the apparatus and method provide replacement values for the faulty sensors so that any process controllers and process monitoring systems that use these sensors can remain in operation during the fault period. The identification of faulty sensors is achieved through the use of a set of structured residual transforms that are uniquely designed to be insensitive to specific subsets of sensors, while being maximally sensitive to sensors not in the subset. Identified faults are classified into one of the types Complete Failure, Bias, Drift, Precision Loss, or Unknown.
Patent AT-E435332-T1 (AT)
Inventor: BYALIK LUDMILA
IPC: D21H13/14
Filed: 1998-10-29
Granted: 2009-07-15
Abstract: A heat seal infusion web packing material for such articles as tea bags and the like includes from 40 to 75% of multicomponent thermoplastic fibers in the heat seal phase. The multicomponent heat seal fibers provide improved seal strength and infusion characteristics over a broad operational window. The multicomponent thermoplastic fibers constitute about 25% by weight of the web material.
Patent AT-E318909-T1 (AT)
Inventor: ROVINSKI BENJAMIN
IPC: C12N15/09
Filed: 1998-12-14
Granted: 2006-03-15
Abstract: Non-infectious, non-replicating immunogenic HIV-like particles are produced by stable long-term constitutive expression in mammalian cells by eliminating elements toxic to the mammalian cells. An expression vector contains a nucleic acid molecule comprising a modified HIV genome devoid of long terminal repeats and wherein Tat and vpr sequences are functionally disabled and a constitutive promoter operatively connected to the modified HIV genome for constitutive expression of the modified genome to produce the HIV-like particles.
Patent AT-E220141-T1 (AT)
Inventor: GOMMEL AXEL
IPC: D21D1/40
Filed: 1999-01-23
Granted: 2002-07-15
Abstract: A process to combine a fiber suspension layer (1) with a further fiber suspension layer (2), where they are both brought together by layer carriers (3,4) into a wedge-shaped gap (5) for water extraction. The sides of the suspension layers (1,2) are restrained by guide surfaces (6,7). The guide surfaces are in contact with the sides of the suspensions directly before they come together and when they are combined, with no guide surface movement, or only a very restricted movement play. The guide surface contours are parallel to the layer carriers (3,4). An Independent claim is included for an apparatus with a fixed displacement body (10) in front of the wedge gap (5), with the guide surfaces (6,7). One guide surface (6) is generally parallel to the outer periphery of the facing cylinder section, and the other guide surface (7) is generally parallel to the facing fourdrinier (8). At least two fiber suspensions are fed into the wedge gap (5) from a stock inlet (11) at the upstream end of the wedge gap (5), between the cylinder (9) and the displacement body (10).
Patent AT-E302305-T1 (AT)
Inventor: ORTWEIN HERMANN
IPC: E01B9/60
Filed: 1999-02-02
Granted: 2005-09-15
Abstract: The track bed (1) has bearings for rails, with elastic intermediate spacers (4) between rail and bearings. The bearings are formed by two consoles (3) located on either side of a rail (2) and fastened to the track bed via screws (5). Bulbous projections (9) on the underside of the consoles engage into groove-like recesses (8) in the track bed. A base plate between track bed and bearing is also fastened by screws.
Patent AT-E501701-T1 (AT)
Inventor: CARROZZI ALESSANDRO
IPC: A61B5/055
Filed: 1999-09-30
Granted: 2011-04-15
Abstract: A machine for diagnostic and/or therapeutic treatment, particularly for Nuclear Magnetic Resonance Imaging, comprises, in combination therewith, a table (2) for supporting the patient, with at least one peripheral recess (302) in the surface of the table (2) or of a part thereof (102) The recess (302) is complemented by a side (201) of the operating surface forming part of the structure of the machine, particularly of the delimitation walls of the cavity or chamber for accommodating the patient. <IMAGE>
Patent AT-E298065-T1 (AT)
Inventor: KLOSE LEONARD
IPC: F21S8/02
Filed: 1999-10-07
Granted: 2005-07-15
Abstract: The light fitting (10) has a HV halogen lamp (17) enclosed by a spot reflector (19), positioned at one focal point (P1) of a elliptical reflector (24), a light output opening (21) positioned at the other focal point (P2) of the elliptical reflector and a lens (27) extending at an angle to the light output opening.
Patent AT-E259108-T1 (AT)
Inventor: HASBERG JOSEF
IPC: B25B9/00
Filed: 1999-10-14
Granted: 2004-02-15
Abstract: The tongs have a body (2) with an elongate opening for reception of part of the flexible electrical cable (3), a relatively pivoted hand grip (5), operated to project into the elongate opening, a driven feed device (10) and a guide sleeve (21) which is pivoted about a transverse axis (6) at one end of the tongs body.
Patent AT-E243925-T1 (AT)
Inventor: VAN DEN BERG KAREL
IPC: A01J5/16
Filed: 1999-04-29
Granted: 2003-07-15
Abstract: The invention relates to a method of automatically milking animals, comprising the following steps:   measuring repeatedly or continuously a quantity which is a measure for the momentary pulse milk flow, (by pulse milk flow is meant the milk flow from a teat during a single suction phase of the milking process); controlling the duration and/or the level of the milk vacuum under the teat during the actual suction phase on the basis of the measured quantity (by suction phase is meant the time during which the teat is exposed to a vacuum during the previously mentioned pulse milk flow).     <IMAGE>
Patent AT-E234258-T1 (AT)
Inventor: BADIALI ROBERTO
IPC: B65H67/06
Filed: 1999-07-21
Granted: 2003-03-15
Abstract: Device for loading spools onto support plates, which are provided with a rod and centring and restraining springs, in order to send the said spools for winding, comprising a device for presentation and centring of the spool on the support, in order to fit the tube of the spool onto the top of the rod, and a spool-fitting device, which can travel a path which corresponds to fitting of the spool, as far as its base stop on the support plate. <IMAGE>
Patent AT-E279145-T1 (AT)
Inventor: ROSHOLM ANDERS
IPC: G01N9/24
Filed: 1999-12-02
Granted: 2004-10-15
Abstract: The method for estimating the Bone Mineral Density (BMD) comprises: obtaining two-dimensional radiographic image data information relating to the cortical bone of at least part of a bone; determining a thickness, t, of the cortical bone; estimating the BMD of the bone to be, BMD = constA x t, where constA is determined from the calibration where values of t have been calibrated to corresponding BMD values for one or more bones.
Patent AT-E229849-T1 (AT)
Inventor: ALLEGRO FERNAND
IPC: B21B1/22
Filed: 1999-01-08
Granted: 2003-01-15
Abstract: The strip passes through an upstream reduction rolling mill cage (2) and a downstream cage (3). The tightening force of the upstream cage (2) is regulated as a function of the tension between the two cages (2, 3), the response time for this regulation being chosen to be very much greater than the response time for the speed of regulation. The strip passes through an upstream reduction rolling mill cage (2) and a downstream cage (3). The speed of the upstream cage (2) is regulated with respect to the downstream cage (3) as a function of the rate of elongation caused by the upstream cage (2). The tightening force of the upstream cage (2) is regulated as a function of the tension between the two cages (2, 3), the response time for this regulation being chosen to be very much greater than the response time for the speed of regulation.
Patent AT-E218420-T1 (AT)
Inventor: IINUMA TOMOYUKI
IPC: B27G13/12
Filed: 1999-01-08
Granted: 2002-06-15
Abstract: A milling cutter for slotting which is provided with a blade body structure capable of producing, without sacrificing strength, an excellent quality of durable film by physical deposition method also on the side flank of a projected cutting blade near the bottom or the outside flank of a bottom edge and comprises blade bodies (22) with a plurality of projected cutting blades (24) disposed in comb shape which are installed on a cutter body (20) at specified pitches in the circumferential direction and a bottom edge (32) formed on the same surface as the cutting face (28) of the projected cutting blade at the bottom between the projected cutting blade and its adjacent projected cutting blade, characterized in that a bottom groove (38) having a with of 90 to 100% of the width of the bottom edge (32) is formed so that the bottom edge is cut off and then the blade bodies are coated with hard film and also a bottom groove having a width of 70 to 100% of the width of the bottom edge is formed at an attack angle of 0 DEG  to 105 DEG  so that the bottom edge is cut off and then the blade bodies (22) are coated with hard film. <IMAGE>